CLINICAL_TRIALS
trial_result
· 2009-05-22
Clinical Trial Update: Phase 2 Study of Darbepoetin Alfa Extended Dosing [Phase 2]
Summary
A Phase 2 study evaluating extended dosing of darbepoetin alfa for anemia in pre-dialysis chronic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Pre-Dialysis | Phase 2 | Status: COMPLETED